Molina Healthcare, Inc $MOH Shares Sold by Securian Asset Management Inc.

Securian Asset Management Inc. lessened its position in Molina Healthcare, Inc (NYSE:MOH) by 3.4% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,832 shares of the company’s stock after selling 100 shares during the period. Securian Asset Management Inc.’s holdings in Molina Healthcare were worth $844,000 as of its most recent SEC filing.

A number of other institutional investors have also modified their holdings of the company. Amalgamated Bank raised its position in shares of Molina Healthcare by 0.3% in the first quarter. Amalgamated Bank now owns 11,580 shares of the company’s stock valued at $3,814,000 after buying an additional 33 shares during the last quarter. Deseret Mutual Benefit Administrators increased its position in Molina Healthcare by 60.7% during the first quarter. Deseret Mutual Benefit Administrators now owns 90 shares of the company’s stock worth $30,000 after purchasing an additional 34 shares during the last quarter. PenderFund Capital Management Ltd. increased its position in Molina Healthcare by 0.4% during the first quarter. PenderFund Capital Management Ltd. now owns 10,071 shares of the company’s stock worth $3,317,000 after purchasing an additional 40 shares during the last quarter. Vestcor Inc increased its position in Molina Healthcare by 2.3% during the first quarter. Vestcor Inc now owns 2,158 shares of the company’s stock worth $711,000 after purchasing an additional 48 shares during the last quarter. Finally, Elequin Capital LP increased its position in Molina Healthcare by 170.6% during the first quarter. Elequin Capital LP now owns 92 shares of the company’s stock worth $30,000 after purchasing an additional 58 shares during the last quarter. Institutional investors and hedge funds own 98.50% of the company’s stock.

Insiders Place Their Bets

In related news, Director Ronna Romney sold 700 shares of the firm’s stock in a transaction on Wednesday, August 6th. The shares were sold at an average price of $153.74, for a total transaction of $107,618.00. Following the completion of the sale, the director directly owned 17,131 shares of the company’s stock, valued at approximately $2,633,719.94. This trade represents a 3.93% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, COO James Woys purchased 10,000 shares of the stock in a transaction that occurred on Monday, August 4th. The shares were purchased at an average cost of $155.94 per share, with a total value of $1,559,400.00. Following the completion of the acquisition, the chief operating officer owned 74,331 shares in the company, valued at approximately $11,591,176.14. This represents a 15.54% increase in their position. The disclosure for this purchase can be found here. 1.10% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Several equities analysts recently commented on MOH shares. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $210.00 price target on shares of Molina Healthcare in a research report on Tuesday, August 26th. JPMorgan Chase & Co. dropped their price target on shares of Molina Healthcare from $272.00 to $184.00 and set a “neutral” rating for the company in a research report on Tuesday, July 29th. Robert W. Baird dropped their price target on shares of Molina Healthcare from $373.00 to $179.00 and set a “neutral” rating for the company in a research report on Friday, July 25th. The Goldman Sachs Group started coverage on shares of Molina Healthcare in a research report on Tuesday, October 14th. They set a “neutral” rating and a $207.00 price target for the company. Finally, Sanford C. Bernstein dropped their price target on shares of Molina Healthcare from $284.00 to $220.00 and set an “outperform” rating for the company in a research report on Friday, September 5th. Three analysts have rated the stock with a Buy rating, twelve have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $222.15.

Molina Healthcare Price Performance

MOH opened at $160.84 on Friday. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.77. Molina Healthcare, Inc has a 52-week low of $151.95 and a 52-week high of $359.97. The company has a 50 day moving average of $184.29 and a two-hundred day moving average of $240.48. The company has a market cap of $8.72 billion, a P/E ratio of 9.96 and a beta of 0.55.

Molina Healthcare (NYSE:MOH) last released its quarterly earnings data on Wednesday, October 22nd. The company reported $1.84 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.97 by ($2.13). Molina Healthcare had a return on equity of 22.60% and a net margin of 1.98%.The business had revenue of $11.48 billion for the quarter, compared to analysts’ expectations of $10.99 billion. During the same quarter in the prior year, the firm earned $6.01 earnings per share. Molina Healthcare’s quarterly revenue was up 11.0% compared to the same quarter last year. Molina Healthcare has set its FY 2025 guidance at 14.000-14.000 EPS. On average, analysts expect that Molina Healthcare, Inc will post 24.4 earnings per share for the current year.

Molina Healthcare Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.